Navigation Links
Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting
Date:7/17/2008

SHENZHEN, China, July 17 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide has announced today that it will highlight all of its marketed in-vitro diagnostic products as well as unveil three new units and reagents at the 2008 Annual American Association for Clinical Chemistry (AACC) conference. The conference will be attended by Mr. Jie Liu, Executive Vice President of International Sales & Marketing and Mr. Wei Wang, Vice President of Research and Development.

Mindray will showcase its entire line of in-vitro diagnostic products at the conference, along with three demo units: the BC-5300 and BC-5380, both of which are Hematology Analyzers, the BA-88A, a Semi-automatic Biochemistry Analyzer, and the first five reagents for the Biochemistry Analyzer. All products are expected to enter the international market in the second half of 2008.

"Mindray's presence at this conference speaks volumes about the direction in which the company is heading," commented Mr. Li Xiting, Mindray's President and Co-Chief Executive Officer. "Presenting at the AACC conference allows us to showcase our high quality products, and demonstrate their efficacy to the medical community."

Mindray's products will be on display at AACC booth 825 in Hall A. The 60th Annual AACC conference will take place from July 29 through July 31 at the Washington Convention Center in Washington D.C. AACC is an international society comprised of medical professionals with an interest in clinical chemistry, clinical laboratory science, and laboratory medicine. Founded in 1948, the society has over 9,000 members and is headquartered in Washington, D.C.

About Mindray

Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has another 12 international sales and service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow, Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver.

For more information, please visit http://www.mindray.com .

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about Mindray's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public filings with the Securities and Exchange Commission. All information provided in this press release is as of July 17, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.

For investor and media inquiries, please contact:

In the U.S:

Evan Smith,

FD

Tel: +1-212-850-5606

Email: evan.smith@fd.com

John Capodanno,

FD

Tel: +1-212-850-5705

Email: john.capodanno@fd.com

In China:

Susan Du

Mindray Medical International Limited

Tel: +86-755-2658-2518

Email: Susan.Du@Mindray.com


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray Announces 20-F Filing
2. Mindrays AS3000(TM) Anesthesia Delivery System Receives U.S. FDA Clearance
3. Mindrays DC-3 Color Ultrasound Gains U.S. FDA 510(k) Clearance
4. Mindray to Attend Morgan Stanley China Summit 2008
5. Mindray Donates Cash and Equipment for Sichuan Earthquake Relief
6. Mindray to Attend Goldman Sachs 29th Annual Global Healthcare Conference
7. Mindray to Hold Conference Call to Discuss the Integration Plan and Closing of the Acquisition of Datascope Corp.s Patient Monitoring Business
8. Mindray Medical Completes Acquisition of Datascopes Patient Monitoring Business
9. Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference
10. Mindray to Report First Quarter 2008 Financial Results on May 7, 2008
11. Mindray to Exhibit at 2008 China International Medical Equipment Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... host a diverse symposium on “Doping in Sport: How the Culture Might ... Richter & Hampton LLP. The symposium will be held at Pepperdine University in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in clinical trials, today announced that Premier Research, a leading clinical development service ... Clinical trials are becoming increasingly complex, due in part to an array of ...
(Date:2/23/2017)... ... February 23, 2017 , ... The ... the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to ... autism spectrum disorder (ASD) to see films in an environment that accommodates their ...
(Date:2/23/2017)... Los Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... of her Smiling Patriot program today with a new Indiegogo campaign ... dental care to homeless veterans in the Los Angeles area, either as a participating ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Thomas ... perseverance and disciplined exercise regime, the author was able to successfully recover. In “ ... all relevant information for various sources on the principals of massage, anatomy , ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... JOLLA, Calif. , Feb. 23, 2017 ... company leading the discovery and development of innovative medicines ... and full year 2016 financial results on Thursday, March ... will host a conference call and webcast on March ... fourth quarter and full year 2016 financial results and ...
(Date:2/23/2017)... -- ... Research and Markets has announced the addition of the "Global Antifungal ... to their offering. The Global Antifungal Drugs Market is ... decade to reach approximately $12.8 billion by 2025. ... given segments on global as well as regional levels presented in the ...
(Date:2/23/2017)... Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company ... and market advanced products and therapies for the Wound ... sectors of healthcare, today announced its record results for ... 2016. Full Year 2016 Highlights are: ... full year 2015 revenue ...
Breaking Medicine Technology: